SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
13.66
-1.20 (-8.08%)
At close: Nov 20, 2026, 4:00 PM EST
14.26
+0.60 (4.36%)
After-hours: Nov 20, 2026, 7:59 PM EST
SLS Market Cap
SLS has a market cap or net worth of $2.94 billion as of November 20, 2026. It is the 4,934th most valuable company in the world and the 1,473rd biggest in the United States. Its market cap has increased by 1,259.04% in one year.
Market Cap
2.94B
Enterprise Value
2.81B
1-Year Change
1,259.04%
Global Rank
Country Rank
#1,473 United States
Category
ChartMarket Cap Chart
Since March 12, 2008, SLS's market cap has increased from $133.40M to $2.94B, an increase of 2,105.65%. That is a compound annual growth rate of 17.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 2.78B | 418.57% |
| Dec 31, 2025 | 537.00M | 633.61% |
| Dec 31, 2024 | 73.20M | 115.29% |
| Dec 29, 2023 | 34.00M | -30.04% |
| Dec 30, 2022 | 48.60M | -44.65% |
| Dec 31, 2021 | 87.80M | 59.64% |
| Dec 31, 2020 | 55.00M | 163.16% |
| Dec 31, 2019 | 20.90M | -22.88% |
| Dec 31, 2018 | 27.10M | 125.83% |
| Dec 29, 2017 | 12.00M | -43.13% |
| Dec 30, 2016 | 21.10M | -91.13% |
| Dec 31, 2015 | 238.00M | 29.77% |
| Dec 31, 2014 | 183.40M | -64.87% |
| Dec 31, 2013 | 522.00M | 404.35% |
| Dec 31, 2012 | 103.50M | 412.38% |
| Dec 30, 2011 | 20.20M | -57.38% |
| Dec 31, 2010 | 47.40M | -36.12% |
| Dec 31, 2009 | 74.20M | -6.31% |
| Dec 31, 2008 | 79.20M | -40.63% |
| Mar 12, 2008 | 133.40M | - |
View and export this data all the way back to 2008. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enliven Therapeutics | 3.42B |
| Iovance Biotherapeutics | 3.38B |
| Viking Therapeutics | 3.30B |
| Legend Biotech | 3.12B |
| Acadia Pharmaceuticals | 3.04B |
| Dyne Therapeutics | 3.00B |
| Telix Pharmaceuticals | 3.00B |
| Vericel | 2.97B |